Luis Cirnes
Porto, 4200135, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: March 21, 2024
Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.
Journal: Frontiers in molecular biosciences
Published: September 21, 2023
Role of Endoscopic Biopsies and Morphologic Features in Predicting Microsatellite Instability Status in Gastric Cancer: A Multicenter Comparative Study of Endoscopic Biopsies and Surgical Specimens.
Journal: The American journal of surgical pathology
Published: June 27, 2023
Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects.
Journal: Cancer treatment and research communications
Published: March 13, 2023
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 13, 2023
Performance of Immunohistochemical and Molecular Methods in Detecting Microsatellite Instability in Gastric Cancer: A Multicenter Study.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: January 02, 2023
Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.
Journal: Frontiers in molecular biosciences
Published: October 28, 2022
Tissue management in precision medicine: What the pathologist needs to know in the molecular era.
Journal: Frontiers in molecular biosciences
Published: June 30, 2022
KIF5B-MET fusion variant in non-small cell lung cancer.
Journal: Pulmonology
Published: January 06, 2022
Reference standards for gene fusion molecular assays on cytological samples: an international validation study.
Journal: Journal of clinical pathology
Published: July 17, 2021
Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: September 04, 2020
Last Updated: 09/26/2026